Chief Executive Officer

Michael “Mick” Farrell is the CEO for ResMed and has held the role since March 2013. Prior to that appointment, Mr. Farrell served as President, Americas for ResMed from 2011 to 2013. He was previously senior vice president of the global business unit for sleep apnea therapeutic and diagnostic devices from 2007 to 2011, and before that he held various senior roles in marketing and business development at the company.


Before joining ResMed in 2000, Mr. Farrell worked in management consulting, biotechnology, chemicals, and metals manufacturing at Arthur D. Little, Genzyme Corporation (now part of Sanofi), The Dow Chemical Company, and BHP Billiton.


Mr. Farrell serves on the board of directors of Zimmer Biomet (NYSE: ZBH), a multi-billion dollar public company that provides implantable musculoskeletal medical devices for patients globally. Mr. Farrell is a member of the Compensation and Management Development committee as well as the Research, Innovation and Technology committee at Zimmer Biomet. Mr. Farrell serves on the ResMed board of directors as well as on the board of directors of the Advanced Medical Technology Association (AdvaMed), based in Washington, DC. Mr. Farrell volunteers as a trustee for two non-profit organizations, the La Jolla Playhouse and the Museum of Man, in his home town of San Diego, California.


Mr. Farrell holds a bachelor of engineering, with first-class honors, from the University of New South Wales, a master of science in chemical engineering from the Massachusetts Institute of Technology, and an M.B.A. from the MIT Sloan School of Management.

Back to top ^



President and Chief Operating Officer

Robert Douglas added president to his role of chief operating officer in March 2013 and, together with ResMed chief executive officer, Mick Farrell, holds full operational responsibility for ResMed and its subsidiaries. Mr. Douglas has served as chief operating officer since September 2011. His former roles with the company include president and chief of global supply operations of ResMed’s Asia Pacific region from May 2011 through September 2011, responsible for the region’s commercial distribution and sales operations, as well as global manufacturing; Asia Pacific chief operating officer from June 2008 through May 2011; Sydney chief operating officer from November 2005 through June 2008, responsible for the company’s manufacturing and research and development; vice president of Operations from 2003 to 2005, responsible for the company’s manufacturing; and vice president of respiratory and cardiac business from 2002 to 2003.


Mr. Douglas first joined ResMed in 2001 as vice president of corporate marketing.


Mr. Douglas has a Master of Business Administration from Macquarie University, a Bachelor’s degree in electrical engineering with first-class honors, and a Bachelor of Science in computer sciences from the University of New South Wales, Sydney.


Back to top ^



Chief Financial Officer

Brett Sandercock has been chief financial officer since January 2006. Previously, he served as vice president of Treasury and Finance from November 2004 until December 2005, and group accountant and controller from 1998 to November 2004.


Before joining ResMed, Mr. Sandercock he was manager of Financial Accounting and Group Reporting at Norton Abrasives, a division of the French multi-national, Saint Gobain, from March 1996 to August 1998. He also held finance and accounting roles from November 1994 to March 1996 at Health Care of Australia, a large private hospital operator. From 1989 to 1994, he worked at Pricewaterhouse Coopers in Sydney, specializing in audits of clients predominantly focused on distribution and manufacturing, financial services and technology.


From 1989 to 1994, Mr. Sandercock worked at PricewaterhouseCoopers in Sydney, specializing in audits of clients predominantly focused on distribution and manufacturing, financial services and technology.


Mr. Sandercock holds a Bachelor of Economics from Macquarie University and is a Certified Chartered Accountant.

Back to top ^



Chief Administrative Officer and Global General Counsel

David Pendarvis was appointed chief administrative officer in May 2011. He has served as Global General Counsel since he joined ResMed in September 2002, and corporate secretary since February 2003. From February 2005 to May 2011, he served as senior vice president of Organizational Development.


Before joining ResMed, Mr. Pendarvis was a partner in the law firm of Gray Cary Ware & Freidenrich LLP from September 2000 until September 2002, where he specialized in intellectual property and general business litigation. From 1986 to 2000, he was a partner with Gibson, Dunn & Crutcher LLP. And from 1984 to 1986 he was a law clerk to the Hon. J. Lawrence Irving, US District Judge, Southern District of California. He is also a director on the Board of Sequenom, Inc.


Mr. Pendarvis holds a Bachelor of Arts from Rice University; a J.D., cum laude, from the University of Texas School of Law, and a Master of Science in executive leadership from the University of San Diego.

Back to top ^



President, Sleep Disordered Breathing and Consumer GBU

Greg Peake became president of ResMed’s Sleep-Disordered Breathing and Consumer Global Business Unit in December 2014. Previously, Mr. Peake was director of Global Product Marketing–Devices in the Sleep-Disordered Breathing Strategic Business Unit since August 2013, and director of Global Product Marketing–Patient Interfaces since February 2012.


Prior to that, Mr. Peake held several roles in product marketing, both in Sydney and San Diego, California, from 2009 to 2012. He joined ResMed in 2005, working as a design engineer in Research & Technology before joining the Global Marketing team in 2007. Prior to ResMed, Mr. Peake worked as a design engineer at Electrolux Home Products, Pty Ltd, and is identified as an inventor or co-inventor on numerous patents granted worldwide.


Mr. Peake holds a Bachelor of Engineering degree with honors in mechatronics and a Master of Science in industrial design from the University of New South Wales.

Back to top ^



President, Cardio-Respiratory Care GBU

Luke Maguire became president of ResMed’s Cardio–Respiratory Care Global Business Unit in December 2014. Previously, Mr. Maguire was senior director of Human Resources for ResMed’s Global Sleep-Disordered Breathing Strategic Business Unit from 2013 to 2014 and senior director of Healthcare Informatics from 2011 to 2013, based in ResMed's San Diego headquarters.


Prior to that appointment, he led several product management teams within the company, including the launch of the S9™ flow generator platform in 2009. Prior to joining ResMed in 2004, Mr. Maguire worked in various design and engineering roles in the automotive industry.


Mr. Maguire holds a Bachelor of Engineering in mechanical engineering and a Ph.D. in engineering from the University of New South Wales.

Back to top ^



President, Healthcare Informatics GBU

Raj Sodhi became president of ResMed’s Healthcare Informatics Global Business Unit in December 2014. He was previously vice president of the global Healthcare Informatics team, helping to build strength in this critical function for the company. Mr. Sodhi joined ResMed through the acquisition of Umbian Inc. in July 2012 where he was co-founder and president.


Prior to this, Mr. Sodhi worked in the financial services industry, designing, developing and managing software as a service (SaaS) solutions: He was senior vice president of Business Development and chief technology officer for Skipjack Financial Services from 2005 to 2009, and co-founder and chief technology officer of TransActive Ecommerce Solutions from 2000 to 2005.


Mr. Sodhi holds a Master of Business Administration and a Bachelor of Science in mathematics and statistics from Dalhousie University.

Back to top ^



President, Americas

Jim Hollingshead was appointed president of ResMed’s Americas region in March 2013. He joined the company in March 2010 as vice president of strategy and business development. In August 2011, his role was expanded to include the leadership of ResMed ventures and initiatives, the unit within ResMed responsible for growing early-stage businesses.


Before joining ResMed, Mr. Hollingshead spent 18 years in strategy consulting, where he worked with senior executives across a wide range of industries. From September 2008 to February 2010, he was a senior partner in the strategy and life sciences practices at Deloitte Consulting, based in San Francisco. Before that, he was West Coast managing partner for Monitor Group, a leading global strategy consulting firm. While at Monitor Group, Mr. Hollingshead worked in various offices around the world and successfully launched and ran three different practices, including a London-based pan-European marketing strategy practice.


Mr. Hollingshead holds a Bachelor of Arts in history and international relations with Highest Distinction from Stanford University, and an Master’s and Ph.D. in political science from the University of California at Berkeley, where he was awarded a graduate student Fellowship by the National Science Foundation.

Back to top ^



President, EMEA-APAC

Anne Reiser became president of ResMed's EMEA-APAC region in December 2014. Previously, Ms. Reiser was president of ResMed’s Europe region. She served as ResMed's France chief operating officer since 2007 after joining as sales director in 2006. Ms. Reiser demonstrated a great track record in building and leading the successful French organization, with both strong sales growth and market share increase.


Prior to joining ResMed, Ms. Reiser’s entire career experience had been in the medical device industry (Mölnlycke, Zimmer, American Home Product). More recently, she worked for Hollister and Medtronic with responsibilities covering both France and other southern European countries.


Ms. Reiser has a Master’s degree from Ecole Supérieure de Commerce de Clermont-Fd (Business School), and a Bachelor’s degree of Law from the University of Clermont-Ferrand.

Back to top ^



President, Innovation & Operations

Don Darkin became president of ResMed's Innovation and Operations in December 2014. Previously, Mr. Darkin was president of ResMed’s Sleep-Disordered Breathing (SDB) Strategic Business Unit and senior vice president of Strategic Business Unit–Patient Interfaces since July 2007. Mr. Darkin joined ResMed in August 1999 as vice president of Product Development. In May 2005, he became director of operations in France for ventilation, and subsequently served as vice president of Business Divisions and senior vice president of Global Product Development.


Before joining ResMed, Mr. Darkin served as vice president of Operations for Ambri Pty (Molecular Engineering and Biotechnology) Ltd. In Australia, and vice president of Product Development for Telectronics Medical Systems in Australia and the United States.


Mr. Darkin is identified as an inventor or co-inventor on 81 granted patents worldwide.


Mr. Darkin was educated in the UK in mechanical engineering and has further professional management training at the University of New South Wales and the Massachusetts Institute of Technology.

Back to top ^



Chief Strategy Officer

Hemanth Reddy became chief strategy officer in December 2014 and is responsible for the company’s global corporate strategy, venture investments and development functions. Prior to joining ResMed in September 2013, Mr. Reddy was a strategy consultant for 14 years, with a focus on growth strategies across consumer products, high tech, biotech and other industries. He advised on a range of issues including corporate strategy, business unit strategy, portfolio strategy and inorganic growth strategy.


He was most recently a principal with Monitor Deloitte, Deloitte Consulting’s Strategy practice, and co-led its San Francisco office. Prior to Deloitte, Mr. Reddy was a partner with Monitor Group where he co-led Corporate Finance activities in North America and shared leadership responsibility for Monitor’s M&A advisory practice.


Mr. Reddy holds a Master of Business Administration in finance, strategy and marketing from the Kellogg School of Management and a Bachelor of Science in computer science from Cornell University’s College of Engineering.

Back to top ^



Chief Information Officer

Frank Lacagnina joined ResMed as the Americas’ vice president of Information Technology in September 2010. He was promoted to chief information officer in February 2012.


Over the past 28 years, Mr. Lacagnina has led IT organizations within semiconductor manufacturing, financial, government, health insurance and medical device organizations. Earlier in his career, he spent 14 years introducing innovative technical business solutions for Motorola’s Semiconductor product sector, and also at the Motorola spin-off company ON Semiconductor, where his last role was IT director of Business Applications. He also spent over three years as CIO for a sovereign Indian nation in Scottsdale, Arizona, where his IT organization enabled and helped lead significant growth in services, including the implementation of new public safety, justice administration, patient management and other critical services and systems.


Mr. Lacagnina specializes in the management of global IT organizations, with a focus on organization turnaround and efficiency. He holds a Bachelor of Business Administration from the University of Arizona, with a major in Management of Information Systems. He also earned an Associate of Applied Sciences degree in computer programming/analysis from Pima Community College in Tucson, Arizona. He has completed further studies in leadership and management from the Thunderbird International School of Business and the W.P. Cary Business College at Arizona State University.

Back to top ^


Richie McHaleRichie McHale

Chief Human Resources Officer

Richie McHale was appointed Chief Human Resources Officer in December 2013 and is responsible for linking ResMed’s employee and corporate strategies. Mr. McHale has 25 years’ experience in the life sciences sector, working primarily in commercial roles in pharmaceutical, biotechnology and medical technology industries. Previously, he served as managing director of ResMed’s UK business team, leading strong growth in the region.


Prior to joining ResMed in 2011, Mr. McHale was managing director of UCB Pharma for UK and Ireland. He also served as chair of the European Medicines Group and a member of the Board of Management for the Association of British Pharmaceutical Industry (ABPI).


Mr. McHale earned a Master’s degree in coaching psychology and is affiliated with the British Psychological Society and the Metanoia Institute in London.

Back to top ^

©2000-2013 ResMed. All rights reserved.